Atlas Trials

Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)

Clinical trial NCT01770158 · TERMINATED

Trial details

NCT number
NCT01770158
Sponsor
University of Ulm
Status
TERMINATED
Study type
OBSERVATIONAL
Acute Myeloid Leukemia
Start date
2012-10-01
Primary completion
2018-03-27
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.